Eastern Allergy Conference Product Theaters
Sanofi & Regeneron
Thursday, May 30, 2024
2:30 – 3:15 PM ~ Ponce 1&2
The First FDA-approved Eosinophilic Esophagitis (EoE) Treatment for Adult and Pediatric Patients
Aged 1-year and Older
Ellen Sher, MD
CSL Behring Medical Affairs
Thursday, May 30, 2024
6:35 – 7:20 PM ~ Ponce 1&2
Mystery Theater: “Help, I’m swelling"
Maeve O’Connor, MD
___________________________________________________________________________________
Sanofi & Regeneron
Friday, May 31, 2024
6:55 – 7:40 AM ~ Ponce 1&2 ~ Breakfast Product Theater
A Focus on Type 2 Inflammation in Disease
Leonard Bacharier, MD
Incyte
Friday, May 31, 2024
6:55 – 7:40 AM ~ Ponce 3 ~ Breakfast Product Theater
Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway for JAK inhibition
Nicole Chase, DO
Sanofi & Regeneron
Friday, May 31, 2024
12:30 – 1:15 PM ~ Ponce 1&2 ~ Lunch Product Theater
An Option for Appropriate Patients with Uncontrolled Moderate-to-Severe Asthma
with an Eosinophilic Phenotype
Bob Geng, MD
Grifols
Friday, May 31, 2024
12:30 – 1:15 PM ~ Ponce 3 ~ Lunch Product Theater
PBL: Teenager with Intractable Asthma
Joshua Jacobs, MD, Rohit Katial, MD, Elena Perez, MD, and Russell Settipane, MD
Genentech
Friday, May 31, 2024
6:00 – 7:00 PM ~ Ponce 1&2 ~ Dinner Product Theater
Xolair: A Therapeutic option for IgE Mediated Food Allergies
Matt Greenhawt, MD
_________________________________________________________________________________________
AstraZeneca
Saturday, June 1, 2024
6:55 – 7:40 AM ~ Ponce 1&2 ~ Breakfast Product Theater
What do Thousands of Patients with Severe Asthma Have in Common? Let’s Find Out
Priya Bansal, MD and Kevin Murphy, MD
Takeda
Saturday, June 1, 2024
6:55 – 7:40 AM ~ Ponce 3 ~ Breakfast Product Theater
HYQVIA – Optimizing Ig for People Living with Primary Immunodeficiency (PI)
Vivian Hernandez-Trujillo, MD
Amgen/AstraZeneca
Saturday, June 1, 2024
12:30 – 1:15 PM ~ Ponce 1&2 ~ Lunch Product Theater
Understanding Severe Asthma: Taking a Closer Look at the
Allergic + Eosinophilic Patient Type
Tina Abraham, MD and Sebastian Lighvani, MD
Takeda
Saturday, June 1, 2024
12:30 – 1:15 PM ~ Ponce 3 – Lunch Product Theater
Could it be HAE?
Daniel Soteres, MD
________________________________________________________________________________________
Genentech
Sunday, June 2, 2024
7:25 – 8:10 AM Ponce 1&2 ~ Breakfast Product Theater
Individualizing Care with Novel Approaches for Multiple Food Allergies: Case Challenges
Aikaterini Anagnostou, MD
Novartis
Sunday, June 2, 2024
7:25 – 8:10 AM ~ Ponce 3 ~ Breakfast Product Theater
Exploring Patient Burden and the Role of BTK Signaling in CSU
Jonathan Rodrigues, MD
CSL Behring
Sunday, June 2, 2024
10:30 – 11:30 AM ~ Ponce 3
Exploring the Clinical Consequences and Burden of Hereditary Angioedema:
Optimizing Long-Term Prophylaxis from the Start
John Anderson, MD
____________________________________________________________________________________________
***If you choose to attend the Product Theaters, please note that when they scan your badge you allow access to your contact information.
*Please note that attendance of Product Theaters is an option only available to full conference registrants and is not for CME credit. Entrance requires for your name badge to be scanned; and by attending, you are granting access to your contact information (but not your email address).